Ironwood Pharmaceuticals
IRWD
IRWD
156 hedge funds and large institutions have $2.09B invested in Ironwood Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
23% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 44
8% more funds holding
Funds holding: 145 → 156 (+11)
7.76% less ownership
Funds ownership: 127.44% → 119.69% (-7.8%)
Holders
156
Holding in Top 10
4
Calls
$24M
Puts
$8.25M
Top Buyers
| 1 | +$27.7M | |
| 2 | +$24.8M | |
| 3 | +$21.4M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$17.5M |
| 5 |
HM
HealthCor Management
New York
|
+$10.1M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$13.3M | |
| 3 | -$12M | |
| 4 |
Millennium Management
New York
|
-$6.83M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.2M |